Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an ...
AGEPHA Pharma will supply LODOCO® (low-dose colchicine) for a Cardio Diagnostics (CDIO)-sponsored clinical study to explore the use of Cardio Diagnostics’ PrecisionCHD™ test to identify patients with ...
(MENAFN- EIN Presswire) EINPresswire/ -- GENinCode US Inc the Irvine based predictive genetics company focused on the prevention of coronary heart disease (“CHD” or“Heart Disease”) and risk assessment ...
On Average, 41% More Sensitive Than Current Tests for Predicting Future Heart Disease in Women CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results